Bioxytran Expands Institutional Investor Base with an additional $500,000 Equity Investment
12 juin 2023 09h00 HE
|
BIOXYTRAN, INC.
- Funding in place to meet next regulatory milestone BOSTON, MASSACHUSETTS, June 12, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company...
VERUS INTERNATIONAL ANNOUNCES $500,000 STRATEGIC INVESTMENT FROM ARJ CONSULTING, LLC
31 mai 2019 16h47 HE
|
Verus International, Inc.
Gaithersburg, MD, May 31, 2019 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTC:VRUS) is pleased to announce that it has received a strategic investment from ARJ...